.

Make Better Decisions

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Deloitte
Healthtrust
AstraZeneca
Dow
Argus Health
Daiichi Sankyo
Cantor Fitzgerald
Colorcon
McKesson
Boehringer Ingelheim

Generated: September 25, 2017

DrugPatentWatch Database Preview

Claims for Patent: ► Subscribe

« Back to Dashboard

Claims for Patent: ► Subscribe

Title: 1,2,3,4,5,6-Hexahydro-2,6-methano-3-benzazocines
Abstract:1,2,3,4,5,6-Hexahydro-3-lower alkenyl-6-(R.sup.1)-11-(R.sup.2)-8-hydroxy-2,6-methano-3-benzazocines, wherein R.sup.1 and R.sup.2 are hydrogen or lower alkyl, and certain ethers and esters thereof, are obtained from analogous 3-unsubstituted compounds. The products have pharmacodynamic activity and are useful as antagonists of strong analgesic agents, such as morphine and meperidine, and are useful in humans as agents for producing analgesia.
Inventor(s): Archer; Sydney (Bethlehem, NY)
Assignee: Sterling Drug Inc. (New York, NY)
Application Number:04/342,768
Patent Claims: 1. 1,2,3 ,4,5,6-Hexahydro-3-(3-methyl-2-butenyl)-6,11-dimethyl-8-hydroxy-2,6-methano -3-benzazocine having the structural formula ##STR9##

2. 1,2,3,4,5,6-Hexahydro-3-(2,3-butadien-1-yl)-6,11-dimethyl-8-hydroxy-2,6- m ethano-3-benzazocine having the structural formula ##STR10##

3. cis 1,2,3,4,5,6-Hexahydro-3-(3-methyl-2-butenyl)-6,11-dimethyl-8-hydroxy-2,6-m ethano-3-benzazocine.

4. dextro cis 1,2,3,4,5,6-Hexahydro-3-(3-methyl-2-butenyl)-6,11-dimethyl-8-hydroxy-2,6-m ethano-3-benzazocine.

5. levo cis 1,2,3,4,5,6-Hexahydro-3-(3-methyl-2-butenyl)-6,11-dimethyl-8-hydroxy-2,6-m ethano-3-benzazocine.

6. A nontoxic acid addition salt of 2-.beta.,.beta.-dimethyl-allyl-5,9-dimethyl-2'-hydroxy-6,7-benzmorphan.

7. 2-.beta.,.beta.-Dimethylallyl-5,9-dimethyl-2'-hydroxy-6,7-benzmorphan hydrochloride.

8. Iso-2-.beta. ,.beta.-dimethylallyl-5,9-dimethyl-2'-hydroxy-6,7-benzmorphan.

9. A chemical compound of the class consisting of a free base and its nontoxic, acid addition salts, the free base having the formula: ##STR11## in which R is a member selected from the group consisting of hydrogen, and acetyl, and Y is a polymethylallyl group having 5 to 6 carbon atoms.
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Merck
Cantor Fitzgerald
Cerilliant
Chinese Patent Office
McKesson
Daiichi Sankyo
US Department of Justice
Novartis
Queensland Health
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot